The process of registering drugs in Tanzania is regulated by the Tanzania Food and Drugs Authority (TFDA) that was established under the Tanzania Food, Drugs and Cosmetics Act of 2003.
As provided for under section 22 of the Act, all drugs to be manufactured for sale, imported or supplied must be registered. The person registering it must hold an appropriate licence or permit required and issued by the Authority.
PRE-REGISTRATION OF DRUGS STAGES
Section 18 of the Act provides that no person shall manufacture for sale, sell and supply or store Registration of products regulated under this Act except in premises registered under this section.
Under section 20, an application for a licence and permit should be made to the Authority in the prescribed form and shall be accompanied by such fee as may be prescribed in the regulations.
Application for Manufacturing Drugs
Before issuing such licence or permit, the Authority shall consider the following:
Application for Selling Drugs
Before issuing such licence or permit, the Authority shall consider the following:
THE STEPS OF REGISTERING A DRUG
CRITERIA FOR REGISTRATION
Criteria for registering drugs are provided for under section 51 of the Act as to include:
APPLICATION FOR REGISTRATION
As per section 52, a person who is in the process of registering drugs in Tanzania shall submit their application to the Director General in the prescribed manner and shall be accompanied by application fees, samples and such other particulars as are prescribed in the application guidelines issued by the Authority, and any other information as the Authority may require from time to time.
REGISTRATION OF DRUGS
Section 53 provides that after the Authority receives the application and having conducted investigation, is satisfied that the drug in question is suitable for the purpose for which it is intended, and if it complies with the prescribed requirements it shall approve the registration of that drug to such conditions as it may impose.
After the Authority approves the registration of any such drug, the Director General shall:
Lastly, where the Authority approves, refuses to approve or cancels the registration of a drug, the Director General shall publish in the Gazette a notification of such approval or refusal and shall in such notice specify, the name under which such drug is registered, the qualitative and quantitative content of its active components, the name of the registrant and the registration number.
New Regulations on Business Licensing: Key Updates for Entrepreneurs Introduction: In a significant development for…
Legal Update: Key Points on the Foreign Exchange (Amendment) Regulations, 2023 Key Points: - The…
Legal Update: New Regulations on Companies' Beneficial Ownership Key Points: 1. The Companies (Beneficial Ownership)…
The Personal Data Protection (Personal Data Collection and Processing) Regulations, 2023 By Sunday Ndamugoba and…
The Personal Data Protection (Complaints Settlement Procedures) Regulations, 2023. By Sunday Ndamugoba and Lubaina Hassanali…
Overview of The Personal Data Protection Act 2022 of Tanzania By Sunday Ndamugoba and Lubaina…